Approvals/TGA/TECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial

Approved

STANDARD

TECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial

Roche Products Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: da53f44a60329e39
Product Name: TECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial
Artg Id: 277120
Artg Name: TECENTRIQ atezolizumab (rch) 1200 mg/20 mL injection concentrated vial
Sponsor: Roche Products Pty Ltd
Company Detail Path: /organization/roche-products-pty-ltd
Artg Date: 2017-07-27
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/390abfba5bb3fa787c40de192375f1a4.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/82439dfbb19e458dc53cd622c6b4633a.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

da53f44a60329e39

Type

Standard